Back to VA VANGUARD CAPITAL MANAGEMENT LLC
GANX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in GAIN THERAPEUTICS INC
Yes. Vanguard Capital Management holds 480,269 shares of GANX (Gain Therapeutics), worth $974,946, as of its Q2 2026 13F filing. It increased the position by 80,383 shares (+20.1%) from Q1 2026. Vanguard Capital Management has held GANX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$974,946
Current Shares
480,269
Total Value Change
+$199,167
Total Shares Change
+80,383
Quarter-by-Quarter History
Other major holders of GANX: GREENLIGHT CAPITAL INC, Gotham Asset Management, LLC, MARSHALL WACE, LLP